Clinical efficacy and safety of interleukin-1 blockade in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials.

Shao-Huan Lan,Chi-Kuei Hsu,Shen-Peng Chang,Li-Chin Lu,Chih-Cheng Lai

Annals of medicine（2023）

引用 1|浏览2

暂无评分

摘要

IL-1 blockade does not provide increased survival benefits in hospitalized patients with COVID-19, but it may reduce the need for MV. Furthermore, it is a safe agent for use in the treatment of COVID-19.>.

查看译文

关键词

Anakinra,canakinumab,COVID-19,interleukin-1,SARS-CoV-2

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要